mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.08 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.08 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.09 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.09 |